Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.58 $6.48 Friday, 10th May 2024 FATE stock ended at $4.08. This is 4.62% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 17.83% from a day low at $3.67 to a day high of $4.33.
90 days $3.58 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Jan 04, 2017 $2.72 $2.80 $2.69 $2.73 43 550
Jan 03, 2017 $2.61 $2.87 $2.44 $2.69 22 515
Dec 30, 2016 $2.61 $2.61 $2.40 $2.51 170 681
Dec 29, 2016 $2.70 $2.80 $2.57 $2.59 89 202
Dec 28, 2016 $2.87 $2.95 $2.69 $2.71 58 752
Dec 27, 2016 $2.80 $2.90 $2.80 $2.87 42 819
Dec 23, 2016 $2.77 $2.89 $2.72 $2.83 25 463
Dec 22, 2016 $2.76 $2.81 $2.68 $2.78 100 812
Dec 21, 2016 $2.74 $2.80 $2.70 $2.77 19 190
Dec 20, 2016 $2.74 $2.90 $2.71 $2.75 68 175
Dec 19, 2016 $2.73 $2.90 $2.70 $2.75 111 000
Dec 16, 2016 $2.80 $2.92 $2.78 $2.82 124 882
Dec 15, 2016 $2.82 $2.89 $2.65 $2.81 205 160
Dec 14, 2016 $2.79 $2.93 $2.75 $2.84 90 582
Dec 13, 2016 $2.87 $2.96 $2.76 $2.81 109 394
Dec 12, 2016 $2.94 $3.03 $2.88 $2.89 98 940
Dec 09, 2016 $3.05 $3.20 $2.90 $2.98 109 374
Dec 08, 2016 $2.98 $3.05 $2.94 $3.02 92 847
Dec 07, 2016 $3.07 $3.07 $2.93 $2.99 96 236
Dec 06, 2016 $2.97 $3.13 $2.87 $3.05 87 385
Dec 05, 2016 $3.15 $3.25 $2.71 $2.99 298 419
Dec 02, 2016 $3.01 $3.15 $2.98 $3.11 106 422
Dec 01, 2016 $3.00 $3.13 $2.95 $3.02 214 109
Nov 30, 2016 $3.07 $3.11 $2.88 $2.94 143 624
Nov 29, 2016 $3.10 $3.24 $2.98 $3.09 147 713
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT